Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaussaud

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
Circulation. Cardiovascular Genetics|November 16, 2011
Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiencyMarie-Olivia Chandesris, Arshid Azarine, Kim-Thanh Ong, et al.
Journal of Clinical Medicine|October 27, 2022
Long-Term Prognosis Value of Paravalvular Leak and Patient-Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI RegistryPierre Deharo, Lionel Leroux, Alexis Theron, et al.
Presse Medicale (Paris, France : 1983)|November 13, 2018
Laurence Bouillet, Frederica Defendi, Gaelle Hardy, et al.
Allergy and Asthma Proceedings|July 22, 2022
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needsLaurence Bouillet, Olivier Fain, Guillaume Armengol, et al.
JACC. Cardiovascular Imaging|August 22, 2017
Diagnosis of Infective Endocarditis After TAVR: Value of a Multimodality Imaging ApproachErwan Salaun, Laura Sportouch, Pierre-Antoine Barral, et al.
RMD Open|November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Medicine|July 4, 2012
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national surveyMarie-Olivia Chandesris, Isabelle Melki, Angels Natividad, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2024
Histological characterization of liver involvement in systemic mastocytosisJulien Rossignol, Danielle Canioni, Achille Aouba, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypesLaura Polivka, Marine Madrange, Cristina Bulai-Livideanu, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Circulation. Cardiovascular Genetics|November 16, 2011
Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiencyMarie-Olivia Chandesris, Arshid Azarine, Kim-Thanh Ong, et al.
Journal of Clinical Medicine|October 27, 2022
Long-Term Prognosis Value of Paravalvular Leak and Patient-Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI RegistryPierre Deharo, Lionel Leroux, Alexis Theron, et al.
Presse Medicale (Paris, France : 1983)|November 13, 2018
Laurence Bouillet, Frederica Defendi, Gaelle Hardy, et al.
Allergy and Asthma Proceedings|July 22, 2022
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needsLaurence Bouillet, Olivier Fain, Guillaume Armengol, et al.
JACC. Cardiovascular Imaging|August 22, 2017
Diagnosis of Infective Endocarditis After TAVR: Value of a Multimodality Imaging ApproachErwan Salaun, Laura Sportouch, Pierre-Antoine Barral, et al.
RMD Open|November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Medicine|July 4, 2012
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national surveyMarie-Olivia Chandesris, Isabelle Melki, Angels Natividad, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2024
Histological characterization of liver involvement in systemic mastocytosisJulien Rossignol, Danielle Canioni, Achille Aouba, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypesLaura Polivka, Marine Madrange, Cristina Bulai-Livideanu, et al.
Pageof 25